The MSN4 antibody (e.g., Santa Cruz Biotechnology catalog sc-15550, RRID:AB_672217) is a polyclonal antibody raised against a recombinant protein fragment of Msn4. Key applications include:
Chromatin Immunoprecipitation (ChIP): Used to map genome-wide binding sites of Msn4 during stress responses and metabolic cycles .
Western Blotting: Validates Msn4 protein expression and purification in studies involving recombinant proteins .
Electrophoretic Mobility Shift Assay (EMSA): Confirms Msn4-DNA interactions in promoter regions of target genes .
Msn4, in conjunction with Msn2, activates genes involved in:
Fatty Acid β-Oxidation: Direct binding to promoters of ECI1, FOX2, POT1, POX1, and SPS19 confirmed via EMSA .
Glycolysis and Acetyl-CoA Production: Msn2/4 upregulate glycolytic enzymes (HXK1, ENO2, TDH3) to modulate acetyl-CoA levels during nutrient-limited growth .
ER-Phagy Regulation: The MSN4 antibody helped identify Msn2/4 as activators of ATG39, a gene critical for endoplasmic reticulum autophagy during stress .
ROS Mitigation: Msn4 promotes mitochondrial ROS production, indirectly activating calcineurin signaling for stress adaptation .
ChIP-Seq Data: Msn4 binding peaks were enriched at promoters of stress-response genes (CTT1, SOD2) and metabolic genes (PGM1, GPH1) during the respiratory oscillation cycle .
Functional Redundancy: Msn4 and Msn2 share ~60% of target genes, but MSN4 expression is stress-inducible, unlike constitutively expressed MSN2 .
KEGG: sce:YKL062W
STRING: 4932.YKL062W
Msn4 is a stress-response transcription factor in Saccharomyces cerevisiae that works together with its homolog Msn2 to regulate cellular responses to various stress conditions. These transcription factors bind to stress-response elements (STREs) in gene promoters and activate the expression of target genes . Msn4 is particularly important because it regulates numerous metabolic pathways including fatty acid β-oxidation, glycolysis, and autophagy, making it a central player in cellular adaptation to stress and nutrient limitation . Unlike Msn2 which is constitutively expressed, Msn4 expression is specifically upregulated under stress conditions, suggesting a specialized role in stress adaptation .
Proper validation of Msn4 antibodies is crucial for reliable experimental results. Western blotting with wild-type, msn2Δ and msn4Δ lysates is the primary validation method to confirm antibody specificity . The antibody should detect a band of the appropriate molecular weight in wild-type and msn2Δ samples, but not in msn4Δ samples. Additional validation methods include immunofluorescence microscopy to verify nuclear localization of Msn4 under stress conditions, and ChIP-qPCR to confirm binding to known target genes . Commercial antibodies should be validated by the manufacturer, but researchers should always perform their own validation with appropriate controls specific to their experimental system .
For optimal Msn4 antibody performance, samples should be collected during stress conditions when Msn4 expression is highest. For ChIP-seq analysis, approximately 50 OD of wild-type cycling cells per time point is recommended . When studying stress responses, cells should be harvested after exposure to the appropriate stress condition, such as glucose limitation or stationary phase . Cell lysis should be performed under conditions that preserve protein integrity, typically using mechanical disruption (glass beads) in the presence of protease inhibitors to prevent degradation. For nuclear proteins like Msn4, nuclear extraction protocols may improve signal-to-noise ratios in immunoblotting applications.
Optimizing Msn4 antibodies for ChIP experiments requires careful consideration of several factors. First, timing is critical—ChIP samples should be collected during the reductive/charging (RC) phase of the yeast metabolic cycle when Msn4 binding activity is highest . For time-course experiments, 6 time points evenly distributed across the cycle are recommended to capture phase-specific binding patterns . Cross-linking conditions should be optimized (typically 1% formaldehyde for 15-20 minutes) to efficiently capture DNA-protein interactions without over-fixation. Sonication parameters should be adjusted to generate DNA fragments of 200-500 bp for optimal resolution. When performing ChIP-seq analysis, peaks should be combined across time points using computational tools such as the 'reduce' function from the 'GenomicRanges' package to identify consistent binding sites . Target genes can be identified by examining regions from 700 bp upstream of the start codon to the stop codon for overlap with Msn4 peaks .
Distinguishing between Msn2 and Msn4 binding in dual ChIP experiments presents challenges due to their homology and overlapping binding sites. The most effective approach involves performing parallel ChIP experiments with specific antibodies against each protein, followed by differential analysis . Sequential ChIP (ChIP-reChIP) can also be employed, where material from the first immunoprecipitation is subjected to a second round using the alternate antibody to identify sites bound by both factors. Computational analysis of binding peaks can quantify the degree of overlap between Msn2 and Msn4 binding sites across different time points or conditions . Additionally, experiments in single deletion strains (msn2Δ or msn4Δ) can help isolate the specific contribution of each factor. For definitive binding site identification, electrophoretic mobility shift assays (EMSA) with recombinant proteins should be performed, as demonstrated with the Msn4-His-tagged protein and promoter fragments of β-oxidation pathway genes .
When faced with contradictory Msn4 ChIP-seq and gene expression data, researchers should consider several explanations. First, binding of a transcription factor does not always lead to transcriptional activation or repression, as additional co-factors may be required . In the case of Msn2/4, they can function as both activators and repressors, with 112 genes repressed and 136 genes activated . Second, temporal dynamics should be considered—binding may precede expression changes, or expression changes may occur through indirect mechanisms. To resolve contradictions, integration of multiple data types is essential, including time-course RNA-seq and ChIP-seq data from both wild-type and msn2Δmsn4Δ strains . Differential expression analysis comparing wild-type and mutant strains can help identify "core target genes" that are both bound by Msn4 and differentially expressed . Additionally, motif analysis of bound regions can confirm direct regulation through canonical STRE elements or reveal alternative binding mechanisms .
To effectively study Msn4's role in metabolic regulation, researchers should implement comprehensive experimental designs that integrate multiple antibody-based approaches. A recommended design would include:
Time-course ChIP-seq experiments across the yeast metabolic cycle using Msn4 antibodies to identify temporal binding patterns
Parallel RNA-seq analysis in wild-type and msn2Δmsn4Δ strains to correlate binding with expression changes
Metabolomic profiling to assess the impact on metabolite levels, particularly focusing on glycolytic intermediates and fatty acid oxidation products
Immunofluorescence microscopy to track Msn4 nuclear localization in response to different metabolic conditions
In vitro DNA-binding assays (EMSA) with recombinant Msn4 protein to confirm direct interactions with metabolic gene promoters
This integrated approach has revealed that Msn4 directly regulates glycolytic enzymes (HXK1, GLK1, ENO1, ENO2, PGK1, GPM1, TDH1, TDH3) and fatty acid oxidation genes (ECI1, FOX2, POT1, POX1, SPS19) , providing a comprehensive understanding of Msn4's role in metabolic adaptation to stress.
Successful EMSA experiments with recombinant Msn4 require careful attention to protein purification and reaction conditions. Recombinant Msn4 should be bacterially expressed with a His-tag and purified under native conditions to preserve DNA-binding activity . Protein quality should be verified by immunoblotting before use in EMSA . For promoter analysis, 1000-bp fragments containing predicted Msn4 binding sites should be used, with titration of increasing protein concentrations to demonstrate binding specificity . Negative controls should include promoter regions lacking Msn4 binding sites, such as the DGA1 promoter . Competition assays with unlabeled probes containing wild-type or mutated binding sites can further confirm specificity. Reaction conditions should be optimized for salt concentration, pH, and the presence of non-specific competitors like poly(dI-dC). For visualization of DNA-protein complexes, either radioisotope-labeled or fluorescently labeled DNA probes can be used, with the latter offering advantages in terms of safety and stability.
Non-specific binding is a common challenge with transcription factor antibodies like those targeting Msn4. To address this issue, researchers should implement a multi-faceted approach:
Validation controls: Always include msn4Δ strains as negative controls to identify non-specific bands
Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to reduce background
Antibody titration: Perform dilution series to determine the optimal antibody concentration that maximizes specific signal while minimizing background
Pre-absorption: Incubate antibodies with msn4Δ lysates to deplete antibodies that recognize non-specific epitopes
Wash stringency: Optimize salt concentration and detergent levels in wash buffers to remove non-specifically bound antibodies
Secondary antibody controls: Include controls omitting primary antibody to identify non-specific binding from secondary antibodies
Cross-reactivity testing: Verify whether the antibody cross-reacts with Msn2 due to sequence homology, which may require additional controls
When performing ChIP experiments, include input controls and IgG controls to account for non-specific binding and background signal .
When studying Msn4 under different stress conditions, several experimental considerations are crucial for obtaining reliable results:
Timing of sample collection: Msn4 expression and nuclear localization are dynamic, so precise timing of sample collection is essential. For glucose depletion studies, cells should be harvested after 15 hours of growth in normal (2%) versus high (6%) glucose media
Stress calibration: The intensity and duration of stress should be calibrated to induce Msn4 response without causing cell death. For example, sublethal concentrations of rapamycin should be determined empirically
Strain background effects: Different yeast strain backgrounds may have varying Msn4 responses, so consistent strain usage is important for comparable results
Single vs. multiple stresses: When studying multiple stresses, consider both sequential and simultaneous application, as Msn4 response may differ
Control genes: Include known Msn4 target genes (like HSP12, CTT1) as positive controls to verify stress response activation
Nuclear extraction efficiency: Under stress conditions, Msn4 localizes to the nucleus, so nuclear extraction protocols should be optimized accordingly
Growth phase standardization: Since Msn4 activity varies with growth phase, standardize cell collection by OD600 or cell cycle markers
These considerations ensure that observed changes in Msn4 localization, binding, or activity accurately reflect the physiological response to the specific stress condition being studied.
Msn4 binding patterns that extend into coding regions, as observed in ChIP-seq experiments, present an interesting regulatory phenomenon requiring careful interpretation . This extended binding pattern deviates from the classical view of transcription factors binding primarily to promoter regions and suggests several possible functional mechanisms:
Transcriptional elongation regulation: Msn4 may interact with the elongation machinery to modulate transcription rate or processivity
Co-transcriptional mRNA processing: Binding in coding regions could influence splicing, mRNA stability, or other co-transcriptional processes
Chromatin organization: Msn4 may participate in maintaining chromatin architecture throughout the gene body
Evolutionary conservation: The coding regions of glycolytic genes are more conserved than both their promoter regions and the coding regions of other genes, suggesting functional importance
Technical considerations: Extended binding patterns could represent spreading of crosslinking or technical artifacts that should be validated with alternative methods
To properly interpret these patterns, researchers should correlate binding with gene expression data, examine evolutionary conservation of binding sites, and perform functional studies using mutations in the coding region binding sites to assess their impact on gene regulation .
Comparative analysis of Msn2 and Msn4 binding profiles reveals important insights into their functional relationship:
Overlapping yet distinct roles: Msn2 and Msn4 share a significant proportion of binding sites and target genes, supporting their partially redundant functions, yet each also has unique targets
Temporal dynamics: Both transcription factors show increased binding to the genome during the reductive/charging (RC) phase of the yeast metabolic cycle, but with different intensity patterns
Expression regulation: While Msn2 is constitutively expressed, Msn4 mRNA levels increase specifically during the RC phase, suggesting differential regulation
Target gene classification: Comparative analysis reveals that Msn2/4 primarily regulate genes involved in carbohydrate metabolism and stress response
Functional redundancy analysis: Studies in single and double deletion mutants (msn2Δ, msn4Δ, msn2Δmsn4Δ) demonstrate that the double mutant has more severe phenotypes, confirming functional overlap
These comparative insights help explain why certain phenotypes are observed only in double mutants, while others show partial effects in single mutants. Researchers should utilize both antibodies in parallel experiments to fully characterize the regulatory network and distinguish shared versus specific functions .
Integrating Msn4 ChIP-seq data with metabolic pathway analysis provides comprehensive insights into how this transcription factor orchestrates metabolic adaptations during stress. A systematic approach involves:
Pathway enrichment analysis: Identify statistically overrepresented metabolic pathways among Msn4-bound genes using tools like KEGG or GO enrichment
Binding site distribution analysis: Examine the distribution of Msn4 binding sites across different metabolic pathways to identify preferentially regulated processes
Core target identification: Define core metabolic targets by overlapping ChIP-seq and differential expression data from wild-type versus msn2Δmsn4Δ comparisons
Metabolic flux correlation: Correlate Msn4 binding patterns with measured or predicted metabolic flux changes during stress responses
Network visualization: Construct integrated networks showing how Msn4 targets are interconnected within metabolic pathways
This integrated analysis has revealed that Msn4 directly regulates multiple metabolic pathways, including glycolysis, fatty acid oxidation, trehalose/glycogen metabolism, and mitochondrial respiration . For example, Msn4 binds to the promoters of key glycolytic enzymes and activates their expression specifically during the reductive/charging phase, demonstrating its role as a master regulator of energy metabolism during stress adaptation .
The dual role of Msn4 in stress response and metabolic regulation has significant implications for understanding cellular adaptation mechanisms:
Coordinated adaptation: By simultaneously regulating both stress response genes (HSP12, HSP26, CTT1, SOD1) and metabolic genes (glycolytic enzymes, β-oxidation pathway), Msn4 ensures coordinated cellular adaptation to challenging conditions
Energy homeostasis: Msn4 activation provides alternative energy sources during glucose limitation by upregulating fatty acid β-oxidation genes and glycolytic genes, maintaining ATP production essential for stress survival
Quiescence exit preparation: During stress, Msn4 activates genes involved in trehalose and glycogen metabolism (TPS2, NTH1, ATH1, GPH1), preparing cells for efficient utilization of storage carbohydrates during recovery
Evolutionary conservation implications: The dual regulatory role suggests evolutionary pressure to coordinate stress protection with metabolic adaptation, which may be conserved in higher eukaryotes
Therapeutic target potential: Understanding this dual role provides insights into potential therapeutic targets for metabolic disorders, as similar coordination likely exists in mammals
This integrated function explains why msn2Δmsn4Δ mutants exhibit both decreased stress resistance and growth defects under specific conditions, particularly during adaptation to non-preferred carbon sources or exit from quiescence . The dual role represents an elegant regulatory mechanism ensuring survival during stress while preparing for growth resumption when conditions improve.
Several emerging technologies promise to enhance Msn4 antibody applications in future research:
CUT&RUN and CUT&Tag: These techniques offer higher signal-to-noise ratios than traditional ChIP-seq and require fewer cells, enabling more sensitive detection of Msn4 binding sites with less background
Single-cell protein analysis: Adapting techniques like CyTOF or single-cell western blotting with Msn4 antibodies could reveal cell-to-cell variability in Msn4 expression and activity during stress responses
Proximity labeling: BioID or APEX2 fusions with Msn4 could identify novel protein interaction partners under different stress conditions
Live-cell imaging: Development of intrabodies or nanobodies against Msn4 could enable real-time tracking of its localization and dynamics in living cells
Automated microfluidics: Integration of Msn4 antibody-based assays with microfluidic platforms could enable high-throughput analysis of Msn4 responses to multiple stresses or drug treatments
CRISPR-based transcription factor activity reporters: Coupling CRISPR technology with Msn4-specific antibodies could create sensitive reporters of Msn4 activity
These technologies would provide deeper insights into the temporal and spatial dynamics of Msn4 function during cellular adaptation to stress and metabolic changes.
Advanced computational approaches offer significant potential for improving Msn4 binding site prediction and functional analysis:
Deep learning algorithms: Neural network models trained on ChIP-seq data could improve prediction of condition-specific Msn4 binding sites beyond simple motif-based approaches
Integrative multi-omics analysis: Combining ChIP-seq, RNA-seq, ATAC-seq, and metabolomics data could provide comprehensive models of Msn4 regulatory networks under different conditions
Molecular dynamics simulations: Modeling the structural interactions between Msn4 and DNA could reveal binding preferences and the impact of mutations
Cross-species comparative genomics: Analysis of Msn4 binding site conservation across fungal species could identify core regulatory elements with critical functions
Network-based approaches: Graph theory and network analysis could identify key nodes in Msn4-regulated pathways and predict systemic effects of perturbations
Single-cell data integration: Computational methods for integrating single-cell data could reveal heterogeneity in Msn4 responses within populations
These computational approaches would enhance the prediction of functional Msn4 binding sites by considering context-dependent factors like chromatin accessibility, co-factor availability, and dynamic cellular states, leading to more accurate models of Msn4-mediated regulation .
Optimal storage and handling of Msn4 antibodies is essential for maintaining their specificity and activity:
Storage temperature: Store at -20°C for long-term storage, with aliquoting to prevent freeze-thaw cycles
Working solution preparation: For immunoblotting applications, prepare working dilutions fresh in TBS-T with 5% non-fat dry milk or BSA
Preservatives: Solutions containing 0.02% sodium azide can be stored at 4°C for up to one month
Shipping conditions: Antibodies should be shipped on ice or with cold packs; avoid extended periods at room temperature
Stability testing: Periodically verify antibody activity and specificity using positive control samples
Documentation: Maintain records of lot numbers, validation results, and optimal working concentrations for each application
Avoiding contamination: Use sterile techniques when handling antibody solutions to prevent microbial contamination
Following these guidelines ensures consistent performance across experiments and maximizes the useful lifespan of Msn4 antibodies.
Researchers studying Msn4 function have access to numerous valuable resources:
Strain collections: The Saccharomyces Genome Deletion Project provides msn4Δ strains and double msn2Δmsn4Δ mutants for functional studies
Plasmid repositories: Addgene and Euroscarf offer expression plasmids for Msn4 with various tags for different applications
Antibody sources: Commercial antibodies are available from vendors like Santa Cruz Biotechnology (yE-19, sc-15550)
Genomic databases: SGD (Saccharomyces Genome Database) provides comprehensive information on Msn4 sequence, interactions, and phenotypes
ChIP-seq datasets: Published datasets are available in repositories like GEO and SRA for comparative analysis
Computational tools: Specialized tools for yeast transcription factor binding analysis are available through packages like DynaMO
Protocols and methods: Detailed protocols for ChIP-seq, EMSA, and other techniques are available in published literature